Papers
4
Total Citations
112
H-Index
3
About
Peter Thind is a urologic surgeon and clinical researcher whose work focuses on improving outcomes for bladder cancer patients undergoing radical cystectomy. His primary research areas include robotic-assisted surgery, perioperative care, and health-related quality of life. Thind’s major contribution is leading the BORARC trial—a double-blinded, randomised feasibility study comparing robot-assisted radical cystectomy (RARC) with open surgery. This work is notable for its rigorous methodology, including blinding patients and care providers, which is rare in surgical trials. His 2017 systematic review and meta-analysis (44 citations) synthesised evidence from four RCTs, highlighting comparable complication rates and quality of life between approaches. His 2021 feasibility study (41 citations) demonstrated that blinding is achievable and provided critical data for future definitive trials. Thind’s research has helped clarify the role of robotic surgery in bladder cancer treatment, emphasising patient-centred outcomes. His work is widely cited by surgeons and researchers seeking evidence-based guidance on surgical technique selection, and his protocol paper (2023) outlines next steps for larger multicentre studies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4